The purpose of this trial is to study liquid aripiprazole in patients with stable schizophrenia.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
59
Tablets, Oral, 15 -30 mg, once daily, 2 weeks (days 1 -14).
Oral Solution, Oral, 15-30 ml, once daily, 1 week (days 15 -21).
Local Institution
Anaheim, California, United States
Local Institution
National City, California, United States
Local Institution
North Miami Beach, Florida, United States
Local Institution
Overland Park, Kansas, United States
acceptability
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Local Institution
Staten Island, New York, United States
Local Institution
Oklahoma City, Oklahoma, United States
Local Institution
Falls Church, Virginia, United States